{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:51:18Z","timestamp":1791312678423,"version":"4.3.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2013,10,6]],"date-time":"2013-10-06T00:00:00Z","timestamp":1381017600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s11010-013-1832-2","type":"journal-article","created":{"date-parts":[[2013,10,5]],"date-time":"2013-10-05T14:56:14Z","timestamp":1380984974000},"page":"239-248","source":"Crossref","is-referenced-by-count":24,"title":["Prevention of RhoA activation and cofilin-mediated actin polymerization mediates the antihypertrophic effect of adenosine receptor agonists in angiotensin II- and endothelin-1-treated cardiomyocytes"],"prefix":"10.1007","volume":"385","author":[{"given":"Asad","family":"Zeidan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong Tracey","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morris","family":"Karmazyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,6]]},"reference":[{"key":"1832_CR1","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/BF00172688","volume":"336","author":"D Martens","year":"1987","unstructured":"Martens D, Lohse MJ, Rauch B, Schwabe U (1987) Pharmacological characterization of A1 adenosine receptors in isolated rat ventricular myocytes. Naunyn Schmiedebergs Arch Pharmacol 336:342\u2013348","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"1832_CR2","first-page":"H1088","volume":"257","author":"FD Romano","year":"1989","unstructured":"Romano FD, MacDonald SG, Dobson JG (1989) Adenosine receptor coupling to adenylate cyclase of rat ventricular myocyte membranes. Am J Physiol 257:H1088\u2013H1095","journal-title":"Am J Physiol"},{"key":"1832_CR3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1161\/01.RES.70.1.56","volume":"70","author":"D Xu","year":"1992","unstructured":"Xu D, Kong HY, Liang BT (1992) Expression and pharmacological characterization of a stimulatory subtype of adenosine receptor in fetal chick ventricular myocytes. Circ Res 70:56\u201365","journal-title":"Circ Res"},{"key":"1832_CR4","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0008-6363(98)00112-6","volume":"40","author":"WR Tracey","year":"1998","unstructured":"Tracey WR, Magee W, Masamune H, Oleynek JJ, Hill RJ (1998) Selective activation of adenosine A3 receptors with N 6-[3-chlorobenzyl]-5\u2032-N-methylcarboxamidoadenosine (CB-MECA) provides cardioprotection via KATP channel activation. Cardiovasc Res 40:138\u2013145","journal-title":"Cardiovasc Res"},{"key":"1832_CR5","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1161\/01.CIR.95.6.1363","volume":"95","author":"H Funaya","year":"1997","unstructured":"Funaya H, Kitakaze M, Node K, Minamino T, Komamura K, Hori M (1997) Plasma adenosine levels increase in patients with chronic heart failure. Circulation 95:1363\u20131365","journal-title":"Circulation"},{"key":"1832_CR6","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1023\/A:1007726018470","volume":"12","author":"M Kitakaze","year":"1998","unstructured":"Kitakaze M, Minamino T, Node K, Koretsune Y, Komamura K, Funaya H, Kuzuya T, Hori M (1998) Elevation of plasma adenosine levels may attenuate the severity of chronic heart failure. Cardiovasc Drugs Ther 12:307\u2013309","journal-title":"Cardiovasc Drugs Ther"},{"key":"1832_CR7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1124\/jpet.104.073122","volume":"312","author":"XT Gan","year":"2005","unstructured":"Gan XT, Rajapurohitam V, Haist JV, Chidiac P, Cook MA, Karmazyn M (2005) Inhibition of phenylephrine-induced cardiomyocyte hypertrophy by activation of multiple adenosine receptor subtypes. J Pharmacol Exp Ther 312:27\u201334","journal-title":"J Pharmacol Exp Ther"},{"key":"1832_CR8","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1097\/00004872-199816120-00015","volume":"16","author":"ES Chung","year":"1998","unstructured":"Chung ES, Perlini S, Aurigemma GP, Fenton RA, Dobson JG, Meyer TE (1998) Effects of chronic adenosine uptake blockade on adrenergic responsiveness and left ventricular chamber function in pressure overload hypertrophy in the rat. J Hypertens 16:1813\u20131822","journal-title":"J Hypertens"},{"key":"1832_CR9","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1161\/HYPERTENSIONAHA.108.110833","volume":"51","author":"X Xu","year":"2008","unstructured":"Xu X, Fassett J, Hu X, Zhu G, Lu Z, Li Y, Schnermann J, Bache RJ, Chen Y (2008) Ecto-5\u2032-nucleotidase deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction. Hypertension 51:1557\u20131564","journal-title":"Hypertension"},{"key":"1832_CR10","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1161\/01.RES.0000216039.75913.9e","volume":"98","author":"JH Brown","year":"2006","unstructured":"Brown JH, Del Re DP, Sussman MA (2006) The Rac and Rho hall of fame: a decade of hypertrophic signaling hits. Circ Res 98:730\u2013742","journal-title":"Circ Res"},{"key":"1832_CR11","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1161\/01.RES.0000201960.04223.3c","volume":"98","author":"G Loirand","year":"2006","unstructured":"Loirand G, Gu\u00e9rin P, Pacaud P (2006) Rho kinases in cardiovascular physiology and pathophysiology. Circ Res 98:322\u2013334","journal-title":"Circ Res"},{"key":"1832_CR12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0022-2828(02)00278-X","volume":"35","author":"S Satoh","year":"2003","unstructured":"Satoh S, Ueda Y, Koyanagi M, Kadokami T, Sugano M, Yoshikawa Y, Makino N (2003) Chronic inhibition of Rho kinase blunts the process of left ventricular hypertrophy leading to cardiac contractile dysfunction in hypertension-induced heart failure. J Mol Cell Cardiol 35:59\u201370","journal-title":"J Mol Cell Cardiol"},{"key":"1832_CR13","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1161\/01.CIR.0000127939.16111.58","volume":"109","author":"T Hattori","year":"2004","unstructured":"Hattori T, Shimokawa H, Higashi M, Hiroki J, Mukai Y, Tsutsui H, Kaibuchi K, Takeshita A (2004) Long-term inhibition of Rho-kinase suppresses left ventricular remodeling after myocardial infarction in mice. Circulation 109:2234\u20132239","journal-title":"Circulation"},{"key":"1832_CR14","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/FJC.0b013e31816533b7","volume":"51","author":"S Fukui","year":"2008","unstructured":"Fukui S, Fukumoto Y, Suzuki J, Saji K, Nawata J, Tawara S, Shinozaki T, Kagaya Y, Shimokawa H (2008) Long-term inhibition of Rho-kinase ameliorates diastolic heart failure in hypertensive rats. J Cardiovasc Pharmacol 51:317\u2013326","journal-title":"J Cardiovasc Pharmacol"},{"key":"1832_CR15","doi-asserted-by":"crossref","first-page":"H1804","DOI":"10.1152\/ajpheart.01078.2007","volume":"294","author":"A Phrommintikul","year":"2008","unstructured":"Phrommintikul A, Tran L, Kompa A, Wang B, Adrahtas A, Cantwell D, Kelly DJ, Krum H (2008) Effects of a Rho kinase inhibitor on pressure overload induced cardiac hypertrophy and associated diastolic dysfunction. Am J Physiol Heart Circ Physiol 294:H1804\u2013H1814","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1832_CR16","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.yjmcc.2007.11.018","volume":"44","author":"J Shi","year":"2008","unstructured":"Shi J, Zhang YW, Summers LJ, Dorn GW II, Wei L (2008) Disruption of ROCK1 gene attenuates cardiac dilation and improves contractile function in pathological cardiac hypertrophy. J Mol Cell Cardiol 44:551\u2013560","journal-title":"J Mol Cell Cardiol"},{"key":"1832_CR17","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.yjmcc.2010.08.008","volume":"49","author":"J Shi","year":"2010","unstructured":"Shi J, Zhang YW, Yang Y, Zhang L, Wei L (2010) ROCK1 plays an essential role in the transition from cardiac hypertrophy to failure in mice. J Mol Cell Cardiol 49:819\u2013828","journal-title":"J Mol Cell Cardiol"},{"key":"1832_CR18","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/cvr\/cvm020","volume":"77","author":"A Zeidan","year":"2008","unstructured":"Zeidan A, Javadov S, Chakrabarti S, Karmazyn M (2008) Leptin-induced cardiomyocyte hypertrophy involves selective caveolae and RhoA\/ROCK-dependent p38 MAPK translocation to nuclei. Cardiovasc Res 77:64\u201372","journal-title":"Cardiovasc Res"},{"key":"1832_CR19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cardiores.2006.06.024","volume":"72","author":"A Zeidan","year":"2006","unstructured":"Zeidan A, Javadov S, Karmazyn M (2006) Essential role of Rho\/ROCK-dependent processes and actin dynamics in mediating leptin-induced hypertrophy in rat neonatal ventricular myocytes. Cardiovasc Res 72:101\u2013111","journal-title":"Cardiovasc Res"},{"key":"1832_CR20","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.bbamem.2010.11.016","volume":"1808","author":"JP Headrick","year":"2011","unstructured":"Headrick JP, Peart JN, Reichelt ME, Haseler LJ (2011) Adenosine and its receptors in the heart: regulation, retaliation and adaptation. Biochim Biophys Acta 1808:1413\u20131428","journal-title":"Biochim Biophys Acta"},{"key":"1832_CR21","doi-asserted-by":"crossref","first-page":"H1382","DOI":"10.1152\/ajpheart.00424.2009","volume":"298","author":"T Pang","year":"2010","unstructured":"Pang T, Rajapurohitam V, Cook MA, Karmazyn M (2010) Differential AMPK phosphorylation sites associated with phenylephrine vs. antihypertrophic effects of adenosine agonists in neonatal rat ventricular myocytes. Am J Physiol Heart Circ Physiol 298:H1382\u2013H1390","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1832_CR22","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.cardiores.2004.03.015","volume":"63","author":"SE Hardt","year":"2010","unstructured":"Hardt SE, Sadoshima J (2010) Negative regulators of cardiac hypertrophy. Cardiovasc Res 63:500\u2013509","journal-title":"Cardiovasc Res"},{"key":"1832_CR23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.physiol.65.092101.142243","volume":"65","author":"N Frey","year":"2003","unstructured":"Frey N, Olson EN (2003) Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 65:45\u201379","journal-title":"Annu Rev Physiol"},{"key":"1832_CR24","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1124\/jpet.111.182600","volume":"339","author":"M Moey","year":"2012","unstructured":"Moey M, Rajapurohitam V, Zeidan A, Karmazyn M (2012) Ginseng (Panax quinquefolius) attenuates leptin-induced cardiac hypertrophy through inhibition of p115Rho guanine nucleotide exchange factor-RhoA\/Rho-associated, coiled-coil containing protein kinase-dependent mitogen-activated protein kinase pathway activation. J Pharmacol Exp Ther 339:746\u2013756","journal-title":"J Pharmacol Exp Ther"},{"key":"1832_CR25","doi-asserted-by":"crossref","first-page":"H165","DOI":"10.1152\/ajpheart.00664.2003","volume":"286","author":"C Lan","year":"2004","unstructured":"Lan C, Das D, Wloskowicz A, Vollrath B (2004) Endothelin-1 modulates hemoglobin-mediated signaling in cerebrovascular smooth muscle via RhoA\/Rho kinase and protein kinase C. Am J Physiol Heart Circ Physiol 286:H165\u2013H173","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1832_CR26","doi-asserted-by":"crossref","first-page":"C1062","DOI":"10.1152\/ajpcell.00174.2009","volume":"297","author":"J Bregeon","year":"2009","unstructured":"Bregeon J, Loirand G, Pacaud P, Rolli-Derkinderen M (2009) Angiotensin II induces RhoA activation through SHP2-dependent dephosphorylation of the RhoGAP p190A in vascular smooth muscle cells. Am J Physiol Cell Physiol 297:C1062\u2013C1070","journal-title":"Am J Physiol Cell Physiol"},{"key":"1832_CR27","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1111\/j.1743-6109.2010.01816.x","volume":"7","author":"KJ Allahdadi","year":"2010","unstructured":"Allahdadi KJ, Hannan JL, Tostes RC, Webb RC (2010) Endothelin-1 induces contraction of female rat internal pudendal and clitoral arteries through ETA receptor and rho-kinase activation. J Sex Med 7:2096\u20132103","journal-title":"J Sex Med"},{"key":"1832_CR28","doi-asserted-by":"crossref","first-page":"C1181","DOI":"10.1152\/ajpcell.00328.2010","volume":"300","author":"A Shatanawi","year":"2011","unstructured":"Shatanawi A, Romero MJ, Iddings JA, Chandra S, Umapathy NS, Verin AD, Caldwell RB, Caldwell RW (2011) Angiotensin II-induced vascular endothelial dysfunction through RhoA\/Rho kinase\/p38 mitogen-activated protein kinase\/arginase pathway. Am J Physiol Cell Physiol 300:C1181\u2013C1192","journal-title":"Am J Physiol Cell Physiol"},{"key":"1832_CR29","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.yjmcc.2009.09.012","volume":"47","author":"JC Hunter","year":"2009","unstructured":"Hunter JC, Zeidan A, Javadov S, Kili\u0107 A, Rajapurohitam V, Karmazyn M (2009) Nitric oxide inhibits endothelin-1-induced neonatal cardiomyocyte hypertrophy via a RhoA-ROCK-dependent pathway. J Mol Cell Cardiol 47:810\u2013818","journal-title":"J Mol Cell Cardiol"},{"key":"1832_CR30","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.tcb.2010.01.001","volume":"20","author":"BW Bernstein","year":"2010","unstructured":"Bernstein BW, Bamburg JR (2010) ADF\/cofilin: a functional node in cell biology. Trends Cell Biol 20:187\u2013195","journal-title":"Trends Cell Biol"},{"key":"1832_CR31","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1093\/emboj\/18.3.664","volume":"18","author":"A Brunet","year":"1999","unstructured":"Brunet A, Roux D, Lenormand P, Dowd S, Keyse S, Pouyssegur J (1999) Nuclear translocation of p42\/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry. EMBO J 18:664\u2013674","journal-title":"EMBO J"},{"key":"1832_CR32","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.bbamcr.2010.12.012","volume":"1813","author":"A Plotnikov","year":"2011","unstructured":"Plotnikov A, Zehorai E, Procaccia S, Seger R (2011) The MAPK cascades: signaling components, nuclear roles and mechanisms of nuclear translocation. Biochim Biophys Acta 1813:1619\u20131633","journal-title":"Biochim Biophys Acta"},{"issue":"Pt 5","key":"1832_CR33","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1042\/BST0330891","volume":"33","author":"A Hall","year":"2005","unstructured":"Hall A (2005) Rho GTPases and the control of cell behaviour. Biochem Soc Trans 33(Pt 5):891\u2013895","journal-title":"Biochem Soc Trans"},{"key":"1832_CR34","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0092-8674(00)81011-9","volume":"98","author":"A Sotiropoulos","year":"1999","unstructured":"Sotiropoulos A, Gineitis D, Copeland J, Treisman R (1999) Signal-regulated activation of serum response factor is mediated by changes in actin dynamics. Cell 98:159\u2013169","journal-title":"Cell"},{"key":"1832_CR35","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1139\/H07-053","volume":"32","author":"M Chiquet","year":"2007","unstructured":"Chiquet M, Tun\u00e7-Civelek V, Sarasa-Renedo A (2007) Gene regulation by mechanotransduction in fibroblasts. Appl Physiol Nutr Metab 32:967\u2013973","journal-title":"Appl Physiol Nutr Metab"},{"key":"1832_CR36","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1083\/jcb.200107116","volume":"155","author":"AE Aplin","year":"2001","unstructured":"Aplin AE, Juliano RL (2001) Regulation of nucleocytoplasmic trafficking by cell adhesion receptors and the cytoskeleton. J Cell Biol 155:187\u2013191","journal-title":"J Cell Biol"},{"key":"1832_CR37","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1146\/annurev-biochem-052810-093700","volume":"81","author":"E Mizuno-Yamasaki","year":"2012","unstructured":"Mizuno-Yamasaki E, Rivera-Molina F, Novick P (2012) GTPase networks in membrane traffic. Annu Rev Biochem 81:637\u2013659","journal-title":"Annu Rev Biochem"},{"key":"1832_CR38","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1096\/fj.03-0592fje","volume":"18","author":"S Mozzicato","year":"2004","unstructured":"Mozzicato S, Joshi BV, Jacobson KA, Liang BT (2004) Role of direct RhoA-phospholipase D1 interaction in mediating adenosine-induced protection from cardiac ischemia. FASEB J 18:406\u2013408","journal-title":"FASEB J"},{"key":"1832_CR39","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1172\/JCI44371","volume":"21","author":"SY Xiang","year":"2011","unstructured":"Xiang SY, Vanhoutte D, Del Re DP, Purcell NH, Ling H, Banerjee I, Bossuyt J, Lang RA, Zheng Y, Matkovich SJ, Miyamoto S, Molkentin JD, Dorn GW II, Brown JH (2011) RhoA protects the mouse heart against ischemia\/reperfusion injury. J Clin Investig 21:3269\u20133276","journal-title":"J Clin Investig"},{"key":"1832_CR40","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s12265-010-9192-8","volume":"3","author":"S Miyamoto","year":"2010","unstructured":"Miyamoto S, Del Re DP, Xiang SY, Zhao X, Florholmen G, Brown JH (2010) Revisited and revised: is RhoA always a villain in cardiac pathophysiology? J Cardiovasc Transl Res 3:330\u2013343","journal-title":"J Cardiovasc Transl Res"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-013-1832-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-013-1832-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-013-1832-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T07:45:46Z","timestamp":1564386346000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-013-1832-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,6]]},"references-count":40,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["1832"],"URL":"https:\/\/doi.org\/10.1007\/s11010-013-1832-2","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,6]]}}}